NEPHROCHECK TEST
Device
Astute Medical, Inc.
Total Payments
$372,069
Transactions
271
Doctors
128
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $139,584 | 43 | 18 |
| 2020 | $15,000 | 1 | 0 |
| 2019 | $217,485 | 227 | 116 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $145,684 | 7 | 39.2% |
| Consulting Fee | $68,191 | 16 | 18.3% |
| Travel and Lodging | $47,503 | 18 | 12.8% |
| Honoraria | $32,842 | 24 | 8.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,583 | 15 | 7.7% |
| Unspecified | $27,889 | 5 | 7.5% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $13,885 | 7 | 3.7% |
| Food and Beverage | $7,492 | 179 | 2.0% |
Payments by Type
General
$344,180
266 transactions
Research
$27,889
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VIDAS NEPHROCHECK | bioMerieux | $20,689 | 0 |
| Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury | Astute Medical, Inc. | $1,800 | 0 |
| Study to Identify and Validate Novel Biomarkers from Acutely Ill Patients at Risk for Acute Kidney Injury | Astute Medical, Inc. | $1,800 | 0 |
| Study to Identify and Validate Novel Biomarkers from Heart Surgery Patients at Risk for Acute Kidney Injury | Astute Medical, Inc. | $1,800 | 0 |
| Study to Identify and Validate Novel Biomarkers from Vascular Surgery Patients at Risk for Acute Kidney Injury | Astute Medical, Inc. | $1,800 | 0 |
Top Doctors Receiving Payments for NEPHROCHECK TEST
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $197,809 | 13 |
| , MD | Critical Care Medicine | Orlando, FL | $50,008 | 49 |
| , MD | Specialist | Pittsburgh, PA | $48,892 | 21 |
| , M.D | Emergency Medicine | Shreveport, LA | $9,888 | 2 |
| James Miner | Emergency Medicine | Minnetrista, MN | $9,441 | 3 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Springfield, MA | $9,372 | 8 |
| , MD | Critical Care Medicine | New York, NY | $9,105 | 3 |
| , MD PHD | Anesthesiology | Southborough, MA | $8,498 | 3 |
| , MD | Nephrology | Washington, DC | $7,497 | 3 |
| , MD | Nephrology | San Diego, CA | $7,425 | 3 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Nashville, TN | $3,810 | 15 |
| , M.D | Critical Care Medicine | Chicago, IL | $2,912 | 3 |
| , M.D | Nephrology | Rochester, MN | $1,050 | 1 |
| , MD | Nephrology | Saint Louis, MO | $791.75 | 1 |
| Mitchell Rosner | Nephrology | Charlottesville, VA | $650.00 | 2 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Jacksonville, FL | $256.25 | 4 |
| , MD | Critical Care Medicine | Orange City, FL | $208.61 | 2 |
| , MD | Pulmonary Disease | Celebration, FL | $189.48 | 2 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cherry Hill, NJ | $178.55 | 2 |
| , MD | Internal Medicine | Winston Salem, NC | $159.51 | 2 |
| , MD | Internal Medicine | Jacksonville, FL | $159.51 | 2 |
| , MD | Pediatric Nephrology | Cincinnati, OH | $144.38 | 1 |
| , MD | Nephrology | Nashville, TN | $144.38 | 1 |
| , MD | Critical Care Medicine | Orange City, FL | $143.86 | 3 |
| , MD | Critical Care Medicine | Orange City, FL | $123.24 | 2 |
Ad
Manufacturing Companies
- Astute Medical, Inc. $229,018
- bioMerieux $105,443
- bioMerieux Inc $37,608
Product Information
- Type Device
- Total Payments $372,069
- Total Doctors 128
- Transactions 271
About NEPHROCHECK TEST
NEPHROCHECK TEST is a device associated with $372,069 in payments to 128 healthcare providers, recorded across 271 transactions in the CMS Open Payments database. The primary manufacturer is Astute Medical, Inc..
Payment data is available from 2019 to 2021. In 2021, $139,584 was paid across 43 transactions to 18 doctors.
The most common payment nature for NEPHROCHECK TEST is "Royalty or License" ($145,684, 39.2% of total).
NEPHROCHECK TEST is associated with 5 research studies, including "VIDAS NEPHROCHECK" ($20,689).